Pharmacokinetics of Efavirenz 400 mg Once Daily Coadministered With Isoniazid and Rifampicin in Human Immunodeficiency Virus–Infected Individuals-Reference-Cited by-同舟云学术

Pharmacokinetics of Efavirenz 400 mg Once Daily Coadministered With Isoniazid and Rifampicin in Human Immunodeficiency Virus–Infected Individuals

Author:

Cerrone Maddalena¹,Wang Xinzhu²,Neary Megan³,Weaver Christine¹,Fedele Serge¹,Day-Weber Isaac²,Owen Andrew³,Hill Andrew³,McClure Myra²,Boffito Marta¹²

Affiliation:

1. St Stephen’s Clinical Research, Chelsea and Westminster Hospital, London

2. Jefferiss Research Trust Laboratories, Department of Medicine, Imperial College, London

3. Molecular and Clinical Pharmacology, Institute of Translational Medicine, University of Liverpool, United Kingdom

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Microbiology (medical)

Link

Reference31 articles.

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

5. Interactions anti-tuberculeux – anti-rétroviraux;Médecine et Maladies Infectieuses Formation;2022-06